Cargando…
AMF siRNA treatment of keloid through inhibition signaling pathway of RhoA/ROCK1
A keloid (KD) is a benign dermal fibrotic tumor. Treatment of KDs is challenging and the recurrence rate is high; thus, there is an unmet need to explore new target sites and new treatment methods. As a tumor-associated cytokine, autocrine motility factor (AMF) can effectively stimulate the random a...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chongqing Medical University
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545443/ https://www.ncbi.nlm.nih.gov/pubmed/31193978 http://dx.doi.org/10.1016/j.gendis.2018.05.002 |